Cy Stein
Inventor
Stats
- 7 US patents issued
- 11 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 11 US Applications Filed
- 1045 Total Citation Count
- Mar 21, 2023 Most Recent Filing
- Feb 22, 1988 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| IMCLONE SYSTEMS INCORPORATED | 1
| 1996
|
| THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1
2 | 1988
1992 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 3
2 1 1 | 1996
2001 2002 2004 |
| The Trustees of Columbia University in The City of New York and ImClone Systems, Inc. | 1
| 1996
|
Inventor Addresses
| Address | Duration |
|---|---|
| Gaithersburg, MD | Nov 23, 93 - Feb 15, 94 |
| La Canada Fiintridge, CA, US | Oct 31, 19 - Oct 31, 19 |
| La Canada Flintridge, CA, US | Oct 26, 23 - Oct 26, 23 |
| New City, NY | Dec 29, 98 - Mar 24, 05 |
| New City, NY, US | May 15, 03 - May 15, 03 |
| New York, NY | May 26, 98 - May 26, 98 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 7 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2023/0340,480 | 2023 | METHODS FOR INTRACELLULAR DELIVERY AND ENHANCED GENE TARGETING | 0 |
| 2019/0330,628 | 2019 | METHODS FOR INTRACELLULAR DELIVERY AND ENHANCED GENE TARGETING | 0 |
| 2005/0065,103 | 2005 | Phosphorothioate antisense heparanase oligonucleotides | 0 |
| 6770753 | 2004 | Phosphorothioate antisense heparanase oligonucleotides | 0 |
| 2003/0211,583 | 2003 | Egs molecules that specifically downregulae bcl-xl experession | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.